Turkish Society of Medical Oncology: 19,000 Men Diagnosed Yearly, Privacy Fears Delay Screening
Prostate cancer will be diagnosed in roughly 19,000 Turkish men this year, and privacy fears are delaying the check-ups that catch it early, the Turkish Society of Medical Oncology said in events marking Prostate Cancer Awareness Month.
About 4,800 men die of the disease in the country annually.
BirGün reported that specialists convened under the motto “Prostate shouldn’t wake you, you wake up,” urging men to speak openly about the disease. The cancer, the second most common among Turkish men, often advances without symptoms in its early stages, which makes screening the main line of defense.
Prof. Dr. Bülent Karabulut, chairman of the Turkish Society of Medical Oncology, told the meeting that embarrassment, fear of physical examination, and worry about treatment’s effects on sexual life all push men to postpone health checks. Roughly 30 percent of cases progress without any complaints at all, he said.
The disease is not confined to older men, Karabulut cautioned: it can appear in the forties. Family history sharply raises risk — twice as high for men whose father had prostate cancer, tripled when a brother is affected, and up to four times the population average with two or more first-degree relatives diagnosed.
Key Clinical Takeaways:
- About 19,000 Turkish men are diagnosed with prostate cancer each year, and roughly 4,800 die of it.
- Privacy concerns and embarrassment delay screening; 30 percent of early cases cause no symptoms.
- Blood proteins linked to prostate cancer appear up to 15 years before clinical diagnosis, a long-term study found.
Occupational exposure raises the question of risk
Karabulut pointed to a meta-analysis finding prostate cancer rates 21 percent higher among firefighters than in the general population, and 13 percent higher among petroleum industry workers, according to Birgun. Heavy pesticide exposure among farm workers, and rising risk with flight hours among long-haul pilots, have also been reported.
He urged men to share their occupational histories with their physicians during health assessments. “Geography should not be destiny for prostate cancer,” he said. “Our men should talk to their doctors without hesitation.”
“We should view treatment not only as a physical process but as a whole encompassing the patient’s psychological, social, and family life,” Karabulut said. “Our aim is not merely to treat the disease but to preserve our patients’ quality of life.”
Blood proteins signaled disease 15 years early
Assoc. Prof. Dr. Tülay Eren, a board member of the oncology society, cited a study tracking men’s blood samples over roughly 16 years, examining more than 6,000 proteins. In the 982 men later diagnosed with prostate cancer, 12 disease-associated proteins were detectable 15 years before diagnosis, and seven proteins linked to aggressive course were identified.
Eren stressed the findings do not yet constitute a routine early-detection test, but could allow earlier risk identification and flagging of cases likely to turn aggressive.
Treatment must be tailored, doctors say
The goal of therapy is suppressing testosterone, Eren said — but the hormone can be produced not only by the testes but also by the adrenal glands and tumor cells themselves. Modern treatment therefore aims to sever the cancer cell’s connection to androgens entirely, she said, with systemic options chosen according to stage, tumor biology, and the patient’s overall health.
Assoc. Prof. Dr. Okan Avcı, a medical oncologist, said PSA values alone are insufficient for diagnosis; MRI, biomarkers, and personal risk assessment must be weighed together. Genetic alterations such as BRCA1, BRCA2, HRR, and ATM, detectable through genomic testing, can open targeted treatment options for some patients — two men with the same diagnosis may carry tumors with different biology requiring individualized plans.
Six steps men can take now
Avcı laid out six measures: regular exercise; a balanced Mediterranean-style diet avoiding processed foods and excess salt, fat, and carbohydrate; steering clear of stress, smoking, and exhausting work conditions; protection from environmental chemicals; consistent, adequate sleep to preserve hormonal balance; and personalized screening.
Every man over 50 should discuss prostate cancer risk and PSA testing with his physician even without symptoms, Avcı said. Men with a family history should begin that conversation at 45, and carriers of high-risk genetic changes such as BRCA2 from age 40.
Globally, about 1.5 million people receive a prostate cancer diagnosis each year, according to figures cited at the meeting. Men concerned about urinary difficulty, frequent urination, back pain, or blood in the urine — or who carry the occupational or family risk factors described — can consult a urologist or medical oncologist for individualized screening advice.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.